Novorin (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Novorin, is an alpha‑adrenergic agonist presented as a nasal decongestant for nasal use. It relieves congestion caused by colds, sinusitis, allergic rhinitis and other upper‑respiratory infections in adults and children. GNH USA supplies Novorin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Novorin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novorin, an alpha‑adrenergic nasal decongestant, acts on the vascular component of nasal congestion.

- Common cold: reduces nasal swelling and improves airflow. - Sinusitis: eases blockage of the sinus passages. - Allergic rhinitis: diminishes allergic nasal congestion. - Upper respiratory tract infections: alleviates congestion associated with viral infections.

Side effects are generally mild and transient, but patients should be aware of possible reactions.

Common Side Effects: - Nasal burning or stinging sensation. - Mild headache. - Dryness of the nasal mucosa. - Sneezing. - Transient taste disturbance. - Mild epistaxis (nosebleed).

Serious or Rare Side Effects: - Persistent nasal irritation or ulceration. - Severe hypertension.\n- Rebound congestion after prolonged use (rhinitis medicamentosa). - Allergic reaction with rash, itching or swelling. - Anaphylaxis (very rare).

Novorin should be used according to label directions and medical advice.

- Duration of use: limit to 3‑5 days to avoid rebound congestion. - Age restrictions: not recommended for infants under 6 months. - Pre‑existing conditions: use cautiously if hypertension or cardiovascular disease is present. - Concomitant nasal sprays: avoid using other vasoconstrictive nasal products simultaneously. - Pregnancy and lactation: consult ​   - Store at ambient   -  

The nasal spray  

t